Fractyl Labs Raises $40M Series C To Develop Diabetes Treatments
September 04, 2014 at 07:00 AM EDT
Fractyl Labs, which develops treatments for diabetes, has raised a $40 million Series C round led by Mithril, with participation from returning investors General Catalyst, Bessemer Venture Partners, and Domain Associates. The new capital will be used to fund clinical evaluation of a procedure that Fractyl has developed. Read More